202 related articles for article (PubMed ID: 34160732)
1. Development of patient-reported outcomes item set to evaluate acute treatment toxicity to pelvic online magnetic resonance-guided radiotherapy.
Møller PK; Pappot H; Bernchou U; Schytte T; Dieperink KB
J Patient Rep Outcomes; 2021 Jun; 5(1):47. PubMed ID: 34160732
[TBL] [Abstract][Full Text] [Related]
2. Feasibility, usability and acceptance of weekly electronic patient-reported outcomes among patients receiving pelvic CT- or online MR-guided radiotherapy - A prospective pilot study.
Møller PK; Pappot H; Bernchou U; Schytte T; Mortensen ZV; Brúnni MFÁ; Dieperink KB
Tech Innov Patient Support Radiat Oncol; 2022 Mar; 21():8-15. PubMed ID: 34977367
[TBL] [Abstract][Full Text] [Related]
3. Content Validity of Anatomic Site-Specific Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Sets for Assessment of Acute Symptomatic Toxicities in Radiation Oncology.
Sandler KA; Mitchell SA; Basch E; Raldow AC; Steinberg ML; Sharif J; Cook RR; Kupelian PA; McCloskey SA
Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):44-52. PubMed ID: 30102201
[TBL] [Abstract][Full Text] [Related]
4. Magnetic Resonance-guided Stereotactic Radiotherapy for Localized Prostate Cancer: Final Results on Patient-reported Outcomes of a Prospective Phase 2 Study.
Tetar SU; Bruynzeel AME; Oei SS; Senan S; Fraikin T; Slotman BJ; Moorselaar RJAV; Lagerwaard FJ
Eur Urol Oncol; 2021 Aug; 4(4):628-634. PubMed ID: 32536573
[TBL] [Abstract][Full Text] [Related]
5. Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy.
Westerhoff JM; Daamen LA; Christodouleas JP; Blezer ELA; Choudhury A; Westley RL; Erickson BA; Fuller CD; Hafeez S; van der Heide UA; Intven MPW; Kirby AM; Lalondrelle S; Minsky BD; Mook S; Nowee ME; Marijnen CAM; Orrling KM; Sahgal A; Schultz CJ; Faivre-Finn C; Tersteeg RJHA; Tree AC; Tseng CL; Schytte T; Silk DM; Eggert D; Luzzara M; van der Voort van Zyp JRN; Verkooijen HM; Hall WA
JAMA Netw Open; 2024 May; 7(5):e2410819. PubMed ID: 38691356
[TBL] [Abstract][Full Text] [Related]
6. Acute and Late Adverse Events Associated With Radical Radiation Therapy Prostate Cancer Treatment: A Systematic Review of Clinician and Patient Toxicity Reporting in Randomized Controlled Trials.
Holch P; Henry AM; Davidson S; Gilbert A; Routledge J; Shearsmith L; Franks K; Ingleson E; Albutt A; Velikova G
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):495-510. PubMed ID: 28126299
[TBL] [Abstract][Full Text] [Related]
7. Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study.
Yeung AR; Pugh SL; Klopp AH; Gil KM; Wenzel L; Westin SN; Gaffney DK; Small W; Thompson S; Doncals DE; Cantuaria GHC; Yaremko BP; Chang A; Kundapur V; Mohan DS; Haas ML; Kim YB; Ferguson CL; Deshmukh S; Bruner DW; Kachnic LA
J Clin Oncol; 2020 May; 38(15):1685-1692. PubMed ID: 32073955
[TBL] [Abstract][Full Text] [Related]
8. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
[TBL] [Abstract][Full Text] [Related]
9. Linking the European Organisation for Research and Treatment of Cancer Item Library to the Common Terminology Criteria for Adverse Events.
Gilbert A; Piccinin C; Velikova G; Groenvold M; Kuliś D; Blazeby JM; Bottomley A
J Clin Oncol; 2022 Nov; 40(32):3770-3780. PubMed ID: 35973158
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes after online adaptive MR-guided stereotactic body radiotherapy for pancreatic tumors on a 1.5 T MR-linac.
Eijkelenkamp H; Grimbergen G; Daamen LA; Heerkens HD; van de Ven S; Mook S; Meijer GJ; Molenaar IQ; van Santvoort HC; Paulson E; Erickson BA; Verkooijen HM; Hall WA; Intven MPW
Front Oncol; 2023; 13():1040673. PubMed ID: 37854684
[TBL] [Abstract][Full Text] [Related]
11. Integrating the patient voice with clinician reports to identify a hepatocellular carcinoma-specific subset of treatment-related symptomatic adverse events.
Speck RM; Lenderking WR; Shaw JW
J Patient Rep Outcomes; 2017; 2():35. PubMed ID: 30175317
[TBL] [Abstract][Full Text] [Related]
12. A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results.
Bruynzeel AME; Tetar SU; Oei SS; Senan S; Haasbeek CJA; Spoelstra FOB; Piet AHM; Meijnen P; Bakker van der Jagt MAB; Fraikin T; Slotman BJ; van Moorselaar RJA; Lagerwaard FJ
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1086-1094. PubMed ID: 31419510
[TBL] [Abstract][Full Text] [Related]
13. eRAPID electronic patient self-Reporting of Adverse-events: Patient Information and aDvice: a pilot study protocol in pelvic radiotherapy.
Holch P; Pini S; Henry AM; Davidson S; Routledge J; Brown J; Absolom K; Gilbert A; Franks K; Hulme C; Morris C; Velikova G;
Pilot Feasibility Stud; 2018; 4():110. PubMed ID: 29992040
[TBL] [Abstract][Full Text] [Related]
14. Identifying symptomatic adverse events using the patient-reported outcomes version of the common terminology criteria for adverse events in patients with non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations.
Zhu Y; Jean-Baptiste M; Lenderking WR; Bell JA; Revicki DA; Lin HM; Brake R; Reeve BB
Cancer Med; 2023 Mar; 12(5):5494-5505. PubMed ID: 36583557
[TBL] [Abstract][Full Text] [Related]
15. Validation of the German patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™).
Hagelstein V; Ortland I; Wilmer A; Mitchell SA; Jaehde U
Ann Oncol; 2016 Dec; 27(12):2294-2299. PubMed ID: 27681863
[TBL] [Abstract][Full Text] [Related]
16. Initial clinical experience with magnetic resonance-guided radiotherapy in pediatric patients: Lessons learned from a single institution with proton therapy.
Hall MD; Mittauer KE; Herrera R; Von Werne K; Kotecha R; Kalman NS; McCulloch J; Alvarez D; McAllister NC; Doty DG; Rzepczynski AE; Deere W; Gutierrez AN; Chuong MD
Front Oncol; 2022; 12():1037674. PubMed ID: 36713501
[TBL] [Abstract][Full Text] [Related]
17. The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy.
de Mol van Otterloo SR; Christodouleas JP; Blezer ELA; Akhiat H; Brown K; Choudhury A; Eggert D; Erickson BA; Faivre-Finn C; Fuller CD; Goldwein J; Hafeez S; Hall E; Harrington KJ; van der Heide UA; Huddart RA; Intven MPW; Kirby AM; Lalondrelle S; McCann C; Minsky BD; Mook S; Nowee ME; Oelfke U; Orrling K; Sahgal A; Sarmiento JG; Schultz CJ; Tersteeg RJHA; Tijssen RHN; Tree AC; van Triest B; Hall WA; Verkooijen HM
Front Oncol; 2020; 10():1328. PubMed ID: 33014774
[No Abstract] [Full Text] [Related]
18. First experience of autonomous, un-supervised treatment planning integrated in adaptive MR-guided radiotherapy and delivered to a patient with prostate cancer.
Künzel LA; Nachbar M; Hagmüller M; Gani C; Boeke S; Zips D; Thorwarth D
Radiother Oncol; 2021 Jun; 159():197-201. PubMed ID: 33812912
[TBL] [Abstract][Full Text] [Related]
19. Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials.
Veitch ZW; Shepshelovich D; Gallagher C; Wang L; Abdul Razak AR; Spreafico A; Bedard PL; Siu LL; Minasian L; Hansen AR
J Natl Cancer Inst; 2021 Aug; 113(8):980-988. PubMed ID: 33616650
[TBL] [Abstract][Full Text] [Related]
20. Selecting a Subset Based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Patient-Reported Symptom Monitoring in Lung Cancer Treatment: Mixed Methods Study.
Veldhuijzen E; Walraven I; Belderbos J
JMIR Cancer; 2021 Sep; 7(3):e26574. PubMed ID: 34519658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
